Home | Welcome to Contract Pharma   
Last Updated Monday, May 25 2015

Print

Breaking News

February 5, 2015
Advances IND studies for ISIS-BIIB4Rx   Read More »
February 5, 2015
Revenues up 7% in the quarter  Read More »
February 5, 2015
Gains portfolio of biosimilars and sterile injectable products  Read More »
February 4, 2015
Signifies growth of 505(b)(2) approval pathway  Read More »
February 4, 2015
Phase II trial shows progression-free survival in beast cancer  Read More »
February 4, 2015
Patent expiries and divestitures impact results  Read More »
February 4, 2015
Sovaldi sales drive record growth  Read More »
February 3, 2015
Expands custom chemical and biochemical manufacturing portfolio  Read More »
February 3, 2015
Sullivan replaces Robert Jamnick, who is retiring  Read More »
February 3, 2015
Foehr brings more than 20 years of pharma experience  Read More »
February 3, 2015
Ligand eligible for $45 million in potential regulatory and commercial milestones  Read More »
February 3, 2015
Masino brings 25 years of industry experience  Read More »
February 2, 2015
Allows for expanded manufacturing and packaging services for U.S. market   Read More »
February 2, 2015
Mylan to manufacture TD-4208 and will lead commercialization in the U.S.  Read More »
February 2, 2015
To provide upstream process development from single-use biodevelopment center in France  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On